Minerva Neurosciences (NERV) Misses Q2 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($1.09), $0.12 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Rockstar Energy founder seeks CEO role at Celsius Holdings
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c
• Chevron Sees Lower End Of $18-$19B Capex Guidance At Yr End - Bloomberg